Inflammation resulting from a combination of gut dysbiosis and NF-κB signaling activation is usually observed in several age-related pathologies such as cardiovascular, metabolic, and neurodegenerative disorders as well as cancer (Tilstra et al., 2011). Here, NFKB1 is linked to cancer.